Author:
Knapp-Gisclon A.,Zerah M.,Mayer-Duverneuil C.,Rambaud C.,de la Grandamison G. Lorin,Alvarez J.-C.
Subject
Pathology and Forensic Medicine,Law
Reference11 articles.
1. The clinical use of ivabradine;Koruth;J. Am. Coll. Cardiol.,2017
2. Ivabradine: from molecular basis to clinical effectiveness;Riccioni;Adv. Ther.,2010
3. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial;Fox;Lancet,2008
4. Haute Autorité de Santé - PROCORALAN (ivabradine), inhibiteur sélectif des canaux If [Internet]. [cité 3 avr 2019]. Disponible sur: https://www.has-sante.fr/portail/jcms/c_2040114/fr/procoralan-ivabradine-inhibiteur-selectif-des-canaux-if.
5. Model-based approaches for ivabradine development in paediatric population, part II: PK and PK/PD assessment;Peigné;J. Pharmacokinet. Pharmacodyn.,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献